메뉴 건너뛰기




Volumn 22, Issue 2, 2012, Pages 1230-1236

Discovery of 3-aryloxy-lactam analogs as potent androgen receptor full antagonists for treating castration resistant prostate cancer

Author keywords

Androgen receptor; AR antagonist; Castration resistant prostate cancer; CRPC; LBD; Ligand efficiency; NHR; Polar surface area; Prostate cancer; PSA

Indexed keywords

3 ARYLOXY LACTAM DERIVATIVE; 4 [3 [4 CYANO 3 (TRIFLUOROMETHYL)PHENYL] 5,5 DIMETHYL 4 OXO 2 THIOXO 1 IMIDAZOLIDINYL] 2 FLUORO N METHYLBENZAMIDE; ANDROGEN RECEPTOR ANTAGONIST; BICALUTAMIDE; BMS 641988; UNCLASSIFIED DRUG;

EID: 84855679381     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.11.068     Document Type: Article
Times cited : (11)

References (23)
  • 14
    • 77949487897 scopus 로고    scopus 로고
    • HLM unbound Clint was calculated with a formula of HLM Clint/Fum. Here HLM Clint corresponds to the intrinsic metabolic clearance (Clint) in microsomes, in μL/min/mg of microsomal protein whereas Fum is the calculated unbound fraction of the drug in human liver microsomes by a computational model developed at Pfizer. Data interpretation as following: Clint <15 μL/min/mg (low clearance); Clint 15-40 μL/min/mg (moderate clearance); Clint >40 (high clearance). HLM data from the same assay has been reported previously. See references: (a) Dong, L.; Marakovits, J.; Hou, X.; Guo, C.; Greasley, S.; Dagostino, E.; Ferre, R.; Johnson, M.C.; Kraynov, E.; Thomson, J.; Pathak, V.; Murray, B.W. Bioorg. Med. Chem. Lett. 2010, 20, 2210-2214.
    • (2010) Bioorg. Med. Chem. Lett. , vol.20 , pp. 2210-2214
    • Dong, L.1    Marakovits, J.2    Hou, X.3    Guo, C.4    Greasley, S.5    Dagostino, E.6    Ferre, R.7    Johnson, M.C.8    Kraynov, E.9    Thomson, J.10    Pathak, V.11    Murray, B.W.12


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.